Issa, Ghayas C. http://orcid.org/0000-0002-4339-8683
DiNardo, Courtney D. http://orcid.org/0000-0001-9003-0390
Article History
Received: 19 February 2021
Revised: 28 April 2021
Accepted: 5 May 2021
First Online: 3 June 2021
Conflict of interest
: G.C.I. received research funding from Celgene, Kura Oncology, Syndax and Novartis, and received consultancy fees from Novartis and Kura Oncology. C.D.D. received research funding from AbbVie, Agios, Novartis, Celgene, Daiichi-Sankyo, Calithera Biosciences, Jazz Pharmaceuticals, Notable Laboratories, and received consultancy fees from AbbVie, Agios, Novartis, Celgene, Daiichi-Sankyo, and Jazz Pharmaceuticals.